Nicolas P.
- Country
- France
- Department
- ICU
Research Overview
- Evaluation of Dobutamine Hydrochloride and Glucose Monohydrate in Septic Cardiomyopathy with Tissue Hypoperfusion: A Randomized Controlled Trial
- Evaluation of Recombinant Human Interferon Gamma 1b for Reducing Secondary Infections in ICU Patients with Sustained Immunosuppression
- A Phase IIa, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Assess the Efficacy, Safety, and Tolerability of AZD4144 in Participants with Sepsis-associated Acute Kidney Injury (SERENIA)
Data & Insights
Has run more than one trial at 9 of 64 partner sites.
Specializations
Critical Care Medicine
This investigator specializes in treating patients with sustained immunosuppression in intensive care settings, with particular focus on preventing secondary infections in critically ill patients.
- ICU-acquired infections
- Immunotherapy applications
- Long-term patient outcomes
The research explores innovative therapeutic approaches using immunomodulatory treatments in critical care scenarios.
Cardiovascular Critical Care
The investigator focuses on treating septic cardiomyopathy and its complications, particularly in patients with tissue hypoperfusion and shock states.
- Septic shock management
- Cardiac support interventions
- Organ failure prevention
Their work involves evaluating cardiovascular interventions in complex critical care scenarios.
Therapeutic Innovations
The investigator explores advanced therapeutic approaches in critical care, including vasopressor support and cardiac intervention strategies.
- Immunomodulatory therapies
- Hemodynamic interventions
- Multi-organ support strategies
Their research encompasses both immunological and cardiovascular therapeutic approaches in critical care medicine.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
